Proof of Concept Study Evaluating the Efficacy and Safety of MIJ821 in Patients With Treatment-resistant Depression
Completed
Depressive Disorder, Treatment-Resistant
Start Date: Feb 2019
Last Updated: Oct 2021
Atlanta, Georgia, USA
/
Oakland, California, USA
/
Rockville, Maryland, USA
and 10 more
Ketamine